| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 08/21/2013 | CN103260651A Silica nanoparticles doped with multiple dyes featuring highly efficient energy transfer and tunable stokes-shift |
| 08/21/2013 | CN103260626A Conjugate for photodynamic diagnosis or therapy and method for preparing same |
| 08/21/2013 | CN103251963A Mixture for curing liver cancer |
| 08/21/2013 | CN103251962A Magnetic resonance contrast material and preparation method thereof, and contrast agent |
| 08/21/2013 | CN103251961A Nano-particle, and preparation method and application thereof |
| 08/21/2013 | CN103251951A Application of P2X2 receptor agonist or opening agent in preparation of anti-depression or anti-anxiety drugs |
| 08/21/2013 | CN103251562A Method for improving stability and shelf-life of liposome complexes |
| 08/21/2013 | CN102596257B Diagnostic composition comprising plasma cations having superior safety profile |
| 08/21/2013 | CN102172411B Nano complex particles with targeted MR (magnetic resonance) development and photothermal therapy performance and preparation method thereof |
| 08/21/2013 | CN101568352B Methods and compositions for improved f-18 labeling of proteins, peptides and other molecules |
| 08/20/2013 | US8512712 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions |
| 08/20/2013 | US8512679 Glassy compositions |
| 08/20/2013 | US8512677 Pyro-glutamate Aβ targeting agents |
| 08/15/2013 | WO2013041810A9 Stable, low-toxicity, sterilizable composition for ophthalmic dying |
| 08/15/2013 | US20130212716 PFKs as Modifiers of the IGFR Pathway and Methods of Use |
| 08/15/2013 | US20130210158 Quaternary nitrogen heterocyclic compounds for detecting aqueous monosaccharides in physiological fluids |
| 08/15/2013 | US20130209369 Nanoparticles based on gadoliium coordination polymers as highly sensitive t1 mri contrast agents |
| 08/15/2013 | US20130209368 Near infrared fluorescent particles and uses thereof |
| 08/15/2013 | US20130209367 Particle and contrast agent having the particle |
| 08/15/2013 | US20130209358 Radiotracer compositions |
| 08/15/2013 | US20130209357 Molecular probes for imaging myelin |
| 08/14/2013 | EP2626085A1 Liquid preparation for oral administration which can be used in ct colonography, and composition for imaging digestive tract |
| 08/14/2013 | EP2626084A1 Combination of sodium chloride and epithelial sodium channel blocker |
| 08/14/2013 | EP2624866A2 Tumor specific antibodies and uses therefor |
| 08/14/2013 | CN103239738A Preparation method of pegylation modified hyperbranched poly(ethylene imine) coated nano-gold particles |
| 08/14/2013 | CN103239737A Fluorescence contrast agent and preparation method thereof |
| 08/14/2013 | CN103239423A Solid lipid nanoparticles including elastin-like polypeptides and use thereof |
| 08/14/2013 | CN102580122B Method for preparing medical disinfection couplant |
| 08/14/2013 | CN102524178B Screening method of febrile convulsion model rat and application thereof |
| 08/14/2013 | CN102499135B Zebra fish vascular injury model for screening vascular injury resisting medicament as well as building method and application thereof |
| 08/14/2013 | CN102284066B Application of whiteruss as optical transparency reinforcing agent |
| 08/14/2013 | CN102268191B Heptamethine indocyanine dye, synthetic method thereof and applications thereof |
| 08/14/2013 | CN102239821B Human hemangioma animal model and constructing method and application thereof |
| 08/14/2013 | CN101703784B Magnetic resonance tumor targeted contrast agent and preparation method thereof |
| 08/14/2013 | CN101700401B Polyalkylene glycol with moiety for conjugating biologicallyactive compound |
| 08/14/2013 | CN101683534B Method for screening qi and blood circulation promotion Chinese medicament components |
| 08/13/2013 | US8509867 Non-invasive measurement of analytes |
| 08/13/2013 | US8507658 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method |
| 08/13/2013 | US8507654 Altered antibodies |
| 08/13/2013 | US8507211 Tuberculosis diagnostic test |
| 08/13/2013 | US8506934 Methods for detection of biological substances |
| 08/13/2013 | US8506932 Tetracyclic indole derivatives as in vivo imaging agents and having peripheralbenzodiazepine receptor affinity (PBR) |
| 08/13/2013 | US8506931 Perylenequinone derivatives and uses thereof |
| 08/13/2013 | CA2687716C Hyperpolarization of compounds for nmr, in particular by means of phip |
| 08/13/2013 | CA2536354C Atopic dermatitis inducer |
| 08/08/2013 | WO2013116527A1 Methods and devices for detection and measurement of analytes |
| 08/08/2013 | WO2013116472A1 Imaging probe including nanoparticle |
| 08/08/2013 | WO2012094620A8 Hydrophobic molecule-induced branched polymer aggregates and their use |
| 08/08/2013 | US20130203870 Animal Models of Atherosclerosis |
| 08/08/2013 | US20130202537 Compositions for labeling nerves and methods of use |
| 08/08/2013 | US20130202535 X-ray visible medical device and preparation method thereof |
| 08/08/2013 | US20130202534 Pathological animal model simultaneously developing testicular pain or discomfort behaviors and urinary frequency |
| 08/08/2013 | US20130202525 Multifunctional nanoplatforms for fluorescence imaging and photodynamic therapy developed by post-loading photosensitizer and fluorophore to polyacrylamide nanoparticles |
| 08/07/2013 | EP2623500A1 Mri contrast agent having gadolinium complex |
| 08/07/2013 | EP2621955A1 Anti-ceacam6 antibodies and uses thereof |
| 08/07/2013 | EP2621852A2 Iron oxide nanocapsule, method of manufacturing the same, and mri contrast agent using the same |
| 08/07/2013 | EP2621542A2 Compositions useful for target, detection, imaging and treatment, and methods of production and use thereof |
| 08/07/2013 | EP2621541A2 Shape-controlled magnetic nanoparticles as t1 contrast agents for magnetic resonance imaging |
| 08/07/2013 | EP2621535A1 Thiazolidine linker for the conjugation of drugs to antibodies |
| 08/07/2013 | EP2621467A2 Fibres and relative woven and non woven tissues for the topic treatment of sexual dysfunctions of the male genital apparatus |
| 08/07/2013 | EP2621420A1 Corneal treatment system and method |
| 08/07/2013 | CN1515244B Protein-stable pharmacological active matter, its preparation and application method |
| 08/07/2013 | CN103237564A Nanoparticle composition and associated method thereof |
| 08/07/2013 | CN103237563A Liquid preparation for oral administration used in CT colonography, and composition for imaging digestive tract |
| 08/07/2013 | CN103237562A MRI contrast agent containing composite particles |
| 08/07/2013 | CN103237492A Micro devices for biomedical applications and methods of using the same |
| 08/07/2013 | CN103237443A Animal model for the evaluation of the efficacy of an HIV vaccine |
| 08/07/2013 | CN103230605A Targeted micro-bubble contrast agent and preparation method thereof |
| 08/07/2013 | CN103230604A Magnetic water-soluble fullerene, and preparation method and application thereof |
| 08/07/2013 | CN103230603A Preparation method of EX527 targeted multifunctional mesoporous silicon nano particle |
| 08/07/2013 | CN103230602A Method for evaluating effectiveness and safety of anti-depression traditional Chinese medicine composition in treating mild/moderate depression |
| 08/07/2013 | CN103230601A Rare earth doped gallium oxide drug-loading body preparation method |
| 08/07/2013 | CN102172410B Construction method of targeted nano particle transmission system for cancer diagnosis and treatment |
| 08/06/2013 | US8501909 Polypeptides having affinity for HER2 |
| 08/06/2013 | US8501694 Method of administering porcine B-domainless fVIII |
| 08/06/2013 | US8501183 Immunogenic compositions and diagnostic and therapeutic uses thereof |
| 08/06/2013 | US8501158 Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents |
| 08/06/2013 | US8501157 Humanized anti-Venezuelan equine encephalitis virus recombinant antibodies |
| 08/06/2013 | US8501156 Method for non-invasive detection and treatment of cerebral aneurysms |
| 08/06/2013 | US8501155 Biochemical markers for acute pulmonary embolism |
| 08/06/2013 | CA2552756C Mouse model for psoriasis and psoriatic arthritis |
| 08/01/2013 | WO2013112643A1 Low density, highly porous nano structure |
| 08/01/2013 | WO2013111759A1 Collagen-like peptide having stealth property and high urinary excretion property |
| 08/01/2013 | WO2013111719A1 Photodynamic diagnostic agent and photobleaching inhibitor |
| 08/01/2013 | WO2013111528A1 Diagnostic agent for tumor |
| 08/01/2013 | WO2013110828A1 Superparamagnetic nanoparticles as a contrast agent for magnetic resonance imaging (mri) of magnetic susceptibility (t2*) |
| 08/01/2013 | WO2013048222A3 Peptide for synthesizing silica, and use thereof |
| 08/01/2013 | US20130195935 Abuse-proofed dosage form |
| 08/01/2013 | US20130195768 Cest systems exhibiting a concentration independent responsiveness |
| 08/01/2013 | US20130195767 Magnetic Nanoparticles |
| 08/01/2013 | US20130195766 Ultrafine nanoparticles comprising a functionalized polyorganosiloxane matrix and including metal complexes; method for obtaining same and uses thereof in medical imaging and/or therapy |
| 08/01/2013 | US20130195765 Method for treating and diagnosing cancer by using cell-derived microvesicles |
| 08/01/2013 | US20130195764 Nanoparticle Targeting to Ischemia for Imaging and Therapy |
| 08/01/2013 | US20130195758 Paa nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded |
| 08/01/2013 | US20130195755 Micellular combination comprising a nanoparticle and a plurality of surfmer ligands |
| 08/01/2013 | US20130195752 Functionalized nanoparticles and methods of use thereof |
| 08/01/2013 | US20130195751 Self-assembed conjugate and use thereof |
| 07/31/2013 | EP2620144A1 Staining Composition |
| 07/31/2013 | EP2619238A1 Novel block copolymer and micelle compositions and methods of use thereof |
| 07/31/2013 | EP2618849A2 Multivalent fluorescent probes |